Sabra Health Care REIT Inc is a healthcare facility real estate investment trust... Show more
Sabra Health Care REIT, Inc. (SBRA) is a self-administered, self-managed real estate investment trust focused on owning and investing in healthcare real estate across the United States and Canada. The company primarily targets senior housing, skilled nursing, and transitional care properties, leasing them under triple-net leases or managing them directly through third-party operators.
SBRA's core business model emphasizes long-term leases and managed senior housing operating portfolio (SHOP) properties, providing stable rental income while capitalizing on demographic trends like the aging baby boomer population. In the competitive healthcare REIT sector, SBRA holds a solid position with a diversified tenant base, low leverage at around 5x net debt to Adjusted EBITDA, and ample liquidity exceeding $1.2 billion. These fundamentals, including strong rent coverage and NOI growth in senior housing, underpin recent stock price stability and quarterly gains amid improving occupancy and investment activity.
Over the last 30 days, SBRA stock exhibited flat performance, rising a modest +0.2% from a closing price of approximately $20.59 to $20.62. The movement was range-bound between $20 and $21, with low volatility reflecting balanced buying and selling pressure post-earnings.
In contrast, the past quarter saw a stronger +12% increase from around $18.41, propelled by a steady uptrend. The stock advanced amid positive catalysts, trading near its 52-week high of $21.07 while maintaining above its 50-day moving average of $19.69, indicating resilient trend-driven momentum.
SBRA's flat 30-day price movement stemmed from a mix of supportive analyst actions and sector stability. Firms like Truist raised price targets to $22 from $21, Scotiabank to $21 from $20, and UBS to $21 from $20, citing strong senior housing momentum and 2026 guidance. These upgrades sustained buyer interest, but modest pullbacks occurred amid broader REIT rotation and profit-taking after the stock hit near 52-week highs.
Company-specific positives included robust same-property cash NOI growth of 12.6% in senior housing during Q4 2025, with occupancy improvements. Macro factors, such as stabilizing interest rates reducing borrowing costs via recent refinancing, aided sentiment. No major negative news emerged, keeping the stock range-bound with steady volume around 2.5-3 million shares daily.
The quarter's +12% gain was fueled by Q4 2025 earnings on February 13, where AFFO of $0.38 slightly missed but was offset by upbeat 2026 guidance projecting 5% normalized AFFO growth to $1.55-$1.59 per share. Investments totaled $450 million at ~7.5% yields, primarily in managed senior housing, boosting portfolio quality.
Sector developments like demographic-driven senior housing demand and limited new supply supported outperformance. Macro tailwinds included a normalizing yield curve and lower refinancing rates, easing leverage pressures. Institutional activity was mixed, with some stake reductions, but analyst upgrades and a 5.8% yield attracted income investors. Cumulative impacts from portfolio shifts to SHOP (now ~26% of assets) and dispositions of underperforming skilled nursing assets enhanced fundamentals, driving the sustained uptrend.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI trading bots from hundreds available, which analyze and trade thousands of tickers across various markets. These curated bots stand out based on recent performance metrics, win rates, and relevance to current market trends, employing diverse strategies like trend-following, mean reversion, or momentum trading over short-term, medium-term, or long-term timeframes. Users can explore detailed stats including profit factors, drawdowns, and historical returns to identify bots aligning with their risk tolerance and goals. Tickeron provides this section to highlight actionable, data-driven tools for traders seeking an edge. Check out the Trending AI Robots page to discover leading performers today.
Investors should monitor Q1 2026 earnings around May 4 for updates on AFFO delivery, same-store NOI in senior housing, and progress on $240 million in awarded investments, mostly senior living deals closing in Q1-Q2. Industry trends like occupancy stabilization above 90% and labor cost moderation will influence tenant coverage.
The macro environment, including interest rate paths and inflation, remains key given SBRA's leverage and refinancing needs. Strategic developments such as SHOP expansion toward 40% portfolio exposure and further skilled nursing optimizations could shape sentiment. Risks include reimbursement changes or operator challenges, alongside catalysts like equity issuances or acquisitions from the robust pipeline.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SBRA declined for three days, in of 271 cases, the price declined further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on May 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SBRA as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for SBRA turned negative on May 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
SBRA moved below its 50-day moving average on May 29, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SBRA crossed bearishly below the 50-day moving average on June 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where SBRA's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where SBRA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SBRA advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .
SBRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 243 cases where SBRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.695) is normal, around the industry mean (2.726). P/E Ratio (29.730) is within average values for comparable stocks, (58.466). SBRA's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (3.232). Dividend Yield (0.064) settles around the average of (0.059) among similar stocks. P/S Ratio (5.724) is also within normal values, averaging (6.245).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock better than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SBRA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines